The results showed that although the stroke incidence was reduced by 19.1% in the aspirin group compared to the placebo group, the difference did not reach statistical significance.
← all excerpts
Advances in the Treatment and Clinical Management Strategies of Tuberculous Meningitis.
1
—
—